Alternatives to Novo Nordisk
The top Biotech companies similar to Novo Nordisk, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
- Website RHRhythm Pharmaceuticals61BiotechBoston, United States
Biopharmaceutical company focused on rare genetic diseases of obesity.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
Eli Lilly and CompanyBiotechIndianapolis, United StatesGlobal pharmaceutical company focused on developing and manufacturing medicines.
- Website
10FoldMed22HealthcareTel Aviv, IsraelIsraeli startup developing non-invasive technology to treat obesity by reversing insulin resistance.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Rezolute52BiotechRedwood City, United States$220.0MBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website JUJuvenescence Ltd.47BiotechGeorge Town, Cayman Islands$150.0M
Biotech company focused on developing therapies to extend human healthspan and lifespan.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Lutris Pharma39BiotechSan Diego, United States$170.0MLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BioAge Labs53BiotechNew Haven, United StatesBioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Anamnesis Bio42Biotechתל אביב - יפו, IsraelDeveloping novel therapeutics for neurodegenerative diseases using advanced biological insights.
- Website
Mustang Bio41BiotechWorcester, United StatesClinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.
- Website
Cellcolabs55BiotechTel Aviv, Israel$15.5MAI-powered platform for personalized cell therapy development and manufacturing.
- Website
Regenxbio55BiotechRockville, United States$180.0MClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
Sylentis55BiotechMadrid, Spain$135.0MOphthalmic pharmaceutical company developing novel treatments for ocular diseases.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Integra Therapeutics54BiotechBarcelona, Spain$134.8MBiotech company developing next-generation gene writing tools for advanced therapies.
- Website
BioLife Solutions54BiotechBothell, United States$96.4MDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
- Website
Aerska54BiotechDublin, Ireland$32.0MIrish BioTech startup Aerska raises €32 million to enable loved ones to live longer.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website
Biogen36BiotechCambridge, United StatesGlobal biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website RERetro Biosciences48BiotechRedwood City, United States$180.0M
A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.
- Website
Ipsen33BiotechParis, FranceGlobal biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website TRTreeline Biosciences47BiotechCambridge, United States$200.0M
Developing novel therapeutics for challenging diseases using advanced biological insights.
- Website GEGenerate:Biologics47BiotechWaltham, United States$10.0M
Develops and manufactures biologics for therapeutic applications.
- Website JUJuvenescence Uk Ltd47BiotechLondon, United Kingdom$150.0M
Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.
- Website
iSpecimen .46BiotechPlainsboro, United States$1.0MGlobal marketplace connecting researchers with human biospecimens for life science research.
- Website
Lift Biosciences46BiotechCambridge, United Kingdom$18.0MDeveloping advanced cell culture media and bioprocessing solutions for cell and gene therapy.
- Website
Metly46BiotechNew York, United States$2.7MMetly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
Eos SENOLYTIX, .29BiotechCambridge, United StatesDevelops senolytic drugs to clear senescent cells and promote cellular rejuvenation.
- Website ALAlpha9 Theranostics44BiotechVancouver, Canada$10.0M
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
- Website
VISEN Pharmaceuticals43BiotechSan Diego, United States$200.0MVISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.
- Website
Alto Neuroscience43BiotechLos Altos, United States$370.0MAlto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
Compare Novo Nordisk head to head
Side by side on what each one does, what it costs, and what real users report.
- Novo Nordisk vs Rhythm Pharmaceuticals
- Novo Nordisk vs Verdiva Bio
- Novo Nordisk vs Eli Lilly and Company
- Novo Nordisk vs 10FoldMed
- Novo Nordisk vs Amicus Therapeutics
- Novo Nordisk vs Harmony Biosciences Holdings
- Novo Nordisk vs Avidity Biosciences
- Novo Nordisk vs Rezolute
- Novo Nordisk vs Orchard Therapeutics
- Novo Nordisk vs Juvenescence Ltd.

